New Silk Road Investment Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ONC
BeOne Medicines Ltd
ONC
|
+$15.7M |
| 2 |
Alibaba
BABA
|
+$7.96M |
| 3 |
New Oriental
EDU
|
+$5.57M |
| 4 |
Weibo
WB
|
+$4.53M |
| 5 |
HTT
High Templar Tech Ltd
HTT
|
+$2.62M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BZUN
Baozun
BZUN
|
+$4.52M |
| 2 |
Yum China
YUMC
|
+$2.82M |
| 3 |
UXIN
Uxin Ltd
UXIN
|
+$913K |
| 4 |
HDFC Bank
HDB
|
+$446K |
| 5 |
LX
LexinFintech Holdings
LX
|
+$227K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 63.01% |
| 2 | Financials | 15.67% |
| 3 | Communication Services | 11.02% |
| 4 | Healthcare | 5.52% |
| 5 | Technology | 2.62% |
Similar funds
New Silk Road Investment's Q2 2019 Portfolio in Review
As of Q2 2019, New Silk Road Investment held 13 positions worth $277M, up 4% from $266M the previous quarter. Its ten largest holdings account for 98% of the portfolio.
New Silk Road Investment deployed $27.7M of net new capital in Q2 2019, opening 3 new positions and adding to 3 existing holdings. Its largest new stake was BeOne Medicines Ltd: 123,375 shares worth $15.3M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 63% of assets, down from 69% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was Baozun, an estimated $4.52M trimmed.
- New Silk Road Investment's largest Q2 2019 buy was BeOne Medicines Ltd: 123,375 shares worth $15.3M.
- New Silk Road Investment added most to Alibaba in Q2 2019, an estimated $7.96M increase.
- New Silk Road Investment's biggest Q2 2019 reduction was Baozun, cutting an estimated $4.52M.
- New Silk Road Investment fully exited Uxin Ltd in Q2 2019, selling an estimated $913K.
- New Silk Road Investment's ten largest holdings make up 98% of its $277M portfolio in Q2 2019.
- New Silk Road Investment opened 3 new positions and closed 1 in Q2 2019.
- New Silk Road Investment's portfolio value rose 4% quarter-over-quarter to $277M.
Based on New Silk Road Investment's 13F filing for Q2 2019, filed 31 Jul 2019.